Jazz Pharmaceuticals PLC - common

Historical Portfolio Holders from Q1 2014 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Price	Investors
2024 Q1	1.05 M	$126 M	-$5.14 M	$120.42	2
2023 Q4	52.4 K	$6.45 M	+$770 K	$123.00	1
2023 Q3	46.2 K	$5.97 M	+$325 K	$129.44	1
2023 Q2	43.6 K	$5.41 M	+$48.7 K	$123.97	1
2023 Q1	43.3 K	$6.33 M	+$416 K	$146.33	1
2022 Q4	40.4 K	$6.44 M	-$4.35 M	$159.31	1
2022 Q3	75.9 K	$10.1 M	-$92.1 K	$133.29	2
2022 Q2	76.6 K	$12 M	-$167 K	$156.01	2
2022 Q1	77.7 K	$12.1 M	-$1.25 M	$155.67	2
2021 Q4	85.7 K	$10.9 M	+$220 K	$127.40	2
2021 Q3	84 K	$10.9 M	+$2.66 M	$130.21	2
2021 Q2	63.5 K	$11.3 M	+$2.26 M	$177.64	2
2021 Q1	50.8 K	$8.35 M	-$191 K	$164.38	1
2020 Q4	52 K	$8.58 M	+$3.3 K	$165.05	1
2020 Q3	51.9 K	$7.41 M	+$5.4 M	$142.59	1
2020 Q2	18.2 K	$2.01 M	+$426 K	$110.35	2
2020 Q1	14.3 K	$1.43 M	-$116 K	$99.74	1
2019 Q4	15.5 K	$2.31 M	-$1.74 M	$149.28	1
2019 Q3	27.1 K	$3.48 M	-$2.64 M	$128.14	1
2019 Q2	45.6 K	$6.51 M	+$4.23 M	$142.58	3
2019 Q1	16 K	$2.28 M	+$2.28 M	$142.95	1
2018 Q2	43.8 K	$7.54 M	-$278 K	$172.30	1
2018 Q1	45.4 K	$6.86 M	+$1.84 M	$150.99	1
2017 Q4	33.2 K	$4.47 M	$0	$134.64	1
2017 Q3	33.2 K	$4.86 M	$0	$146.27	1
2017 Q2	33.2 K	$5.16 M	-$1.46 M	$155.51	1
2017 Q1	43.3 K	$6.28 M	+$1.44 M	$145.13	2
2016 Q4	33.4 K	$3.64 M	$0	$109.04	1
2016 Q3	33.5 K	$4.07 M	-$2.37 M	$120.06	2
2016 Q2	50.3 K	$7.11 M	-$2.18 M	$141.32	3
2016 Q1	65.8 K	$8.59 M	-$6.53 M	$130.55	4
2015 Q4	112 K	$15.8 M	+$12.4 M	$140.55	4
2015 Q3	23.9 K	$3.17 M	+$2.89 M	$132.73	3
2015 Q2	2.13 K	$374 K	+$153 K	$176.33	3
2015 Q1	1.26 K	$217 K	$0	$172.35	2
2014 Q4	1.26 K	$205 K	+$181 K	$161.44	2
2014 Q3	152	$24 K	-$268 K	$157.89	1
2014 Q2	1.98 K	$289 K	-$4.13 M	$139.83	2
2014 Q1	31.6 K	$4.39 M	-$4.06 M	$138.63	4